Affinis Hospice, Llc 507 North Jefferson Street, Albany, GA, 31702 | |
(229) 435-2109 |
News Archive
A revolutionary biodegradable pellet which slowly releases antibiotics into the middle ear could transform the lives of thousands of children who suffer from glue ear.
At the HIMSS10 Conference at the Georgia World Congress Center in Atlanta, Georgia, IBM introduced Initiate Exchange, a new service that enables health systems to exchange patient data with physicians. The company also announced that Initiate client CareSpark, has been awarded a Social Security Administration contract through the American Recovery and Reinvestment Act.
Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, announces that the data from its completed Phase 2 CUPID clinical study of MYDICAR for the treatment of advanced heart failure is being published today online in Circulation, an American Heart Association journal.
More than 55 percent of adults in the United States lose or break their sunglasses every year, according to a new report by The Vision Council.
Black patients are significantly less likely than their white counterparts to receive therapy for various kinds of cancer, despite recent efforts to close gaps in treatment, according to a study by researchers at Yale School of Medicine published in the January 7 online issue of the journal Cancer.
› Verified 7 days ago
Name | Affinis Hospice, Llc |
---|---|
Location | 507 North Jefferson Street, Albany, Georgia |
Hospice ID | 111690 |
Category | Freestanding Hospice |
Ownership Type | Other |
Profit Type | OTHER |
SSA county code | 390 |
News Archive
A revolutionary biodegradable pellet which slowly releases antibiotics into the middle ear could transform the lives of thousands of children who suffer from glue ear.
At the HIMSS10 Conference at the Georgia World Congress Center in Atlanta, Georgia, IBM introduced Initiate Exchange, a new service that enables health systems to exchange patient data with physicians. The company also announced that Initiate client CareSpark, has been awarded a Social Security Administration contract through the American Recovery and Reinvestment Act.
Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, announces that the data from its completed Phase 2 CUPID clinical study of MYDICAR for the treatment of advanced heart failure is being published today online in Circulation, an American Heart Association journal.
More than 55 percent of adults in the United States lose or break their sunglasses every year, according to a new report by The Vision Council.
Black patients are significantly less likely than their white counterparts to receive therapy for various kinds of cancer, despite recent efforts to close gaps in treatment, according to a study by researchers at Yale School of Medicine published in the January 7 online issue of the journal Cancer.
› Verified 7 days ago
NPI Number | 1215188917 |
Organization Name | Affinis Hospice, Llc |
Address | 507 N Jefferson St Albany, Georgia, 31701 |
Phone Number | (229)435-2109 |
News Archive
A revolutionary biodegradable pellet which slowly releases antibiotics into the middle ear could transform the lives of thousands of children who suffer from glue ear.
At the HIMSS10 Conference at the Georgia World Congress Center in Atlanta, Georgia, IBM introduced Initiate Exchange, a new service that enables health systems to exchange patient data with physicians. The company also announced that Initiate client CareSpark, has been awarded a Social Security Administration contract through the American Recovery and Reinvestment Act.
Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, announces that the data from its completed Phase 2 CUPID clinical study of MYDICAR for the treatment of advanced heart failure is being published today online in Circulation, an American Heart Association journal.
More than 55 percent of adults in the United States lose or break their sunglasses every year, according to a new report by The Vision Council.
Black patients are significantly less likely than their white counterparts to receive therapy for various kinds of cancer, despite recent efforts to close gaps in treatment, according to a study by researchers at Yale School of Medicine published in the January 7 online issue of the journal Cancer.
› Verified 7 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 98.9 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 94.4 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 96.6 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 92.9 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 100.0 | 97.3 |
Patients who got timely treatment for shortness of breath | 78.1 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
A revolutionary biodegradable pellet which slowly releases antibiotics into the middle ear could transform the lives of thousands of children who suffer from glue ear.
At the HIMSS10 Conference at the Georgia World Congress Center in Atlanta, Georgia, IBM introduced Initiate Exchange, a new service that enables health systems to exchange patient data with physicians. The company also announced that Initiate client CareSpark, has been awarded a Social Security Administration contract through the American Recovery and Reinvestment Act.
Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, announces that the data from its completed Phase 2 CUPID clinical study of MYDICAR for the treatment of advanced heart failure is being published today online in Circulation, an American Heart Association journal.
More than 55 percent of adults in the United States lose or break their sunglasses every year, according to a new report by The Vision Council.
Black patients are significantly less likely than their white counterparts to receive therapy for various kinds of cancer, despite recent efforts to close gaps in treatment, according to a study by researchers at Yale School of Medicine published in the January 7 online issue of the journal Cancer.
› Verified 7 days ago
Home Health Aides | 6 |
Counselors | 1 |
Medical Social Workers | 1 |
Physicians | 0.25 |
Registered Nurses | 4 |
Other Personnel | 3 |
Total Employees | 15.25 |
---|
News Archive
A revolutionary biodegradable pellet which slowly releases antibiotics into the middle ear could transform the lives of thousands of children who suffer from glue ear.
At the HIMSS10 Conference at the Georgia World Congress Center in Atlanta, Georgia, IBM introduced Initiate Exchange, a new service that enables health systems to exchange patient data with physicians. The company also announced that Initiate client CareSpark, has been awarded a Social Security Administration contract through the American Recovery and Reinvestment Act.
Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, announces that the data from its completed Phase 2 CUPID clinical study of MYDICAR for the treatment of advanced heart failure is being published today online in Circulation, an American Heart Association journal.
More than 55 percent of adults in the United States lose or break their sunglasses every year, according to a new report by The Vision Council.
Black patients are significantly less likely than their white counterparts to receive therapy for various kinds of cancer, despite recent efforts to close gaps in treatment, according to a study by researchers at Yale School of Medicine published in the January 7 online issue of the journal Cancer.
› Verified 7 days ago
Others | 7 |
Total Volunteers | 7 |
---|
News Archive
A revolutionary biodegradable pellet which slowly releases antibiotics into the middle ear could transform the lives of thousands of children who suffer from glue ear.
At the HIMSS10 Conference at the Georgia World Congress Center in Atlanta, Georgia, IBM introduced Initiate Exchange, a new service that enables health systems to exchange patient data with physicians. The company also announced that Initiate client CareSpark, has been awarded a Social Security Administration contract through the American Recovery and Reinvestment Act.
Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, announces that the data from its completed Phase 2 CUPID clinical study of MYDICAR for the treatment of advanced heart failure is being published today online in Circulation, an American Heart Association journal.
More than 55 percent of adults in the United States lose or break their sunglasses every year, according to a new report by The Vision Council.
Black patients are significantly less likely than their white counterparts to receive therapy for various kinds of cancer, despite recent efforts to close gaps in treatment, according to a study by researchers at Yale School of Medicine published in the January 7 online issue of the journal Cancer.
› Verified 7 days ago
Phoebe Hospice Location: 320 Foundation Lane, Albany, Georgia, 31707 Phone: (229) 435-2109 |
Affinis Hospice, Llc Location: 507 North Jefferson Street, Albany, Georgia, 31702 Phone: (229) 435-2109 |